COMMUNIQUÉS West-GlobeNewswire

-
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
06/11/2024 -
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
06/11/2024 -
Viemed Healthcare Announces Third Quarter 2024 Financial Results
06/11/2024 -
Monthly information on share capital and company voting rights
06/11/2024 -
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/11/2024 -
BrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi®
06/11/2024 -
Surrozen to Present at Upcoming Healthcare Investor Conferences
06/11/2024 -
DBV Technologies Reports Third Quarter 2024 Financial Results
06/11/2024 -
DBV Technologies publie ses résultats financiers du troisième trimestre 2024
06/11/2024 -
Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
06/11/2024 -
Amedisys Reports Third Quarter 2024 Financial Results
06/11/2024 -
STERIS Announces Financial Results for Fiscal 2025 Second Quarter
06/11/2024 -
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
06/11/2024 -
SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update
06/11/2024 -
MacroGenics to Participate in Upcoming Investor Conferences
06/11/2024 -
Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma
06/11/2024 -
Certara Reports Third Quarter 2024 Financial Results
06/11/2024 -
Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
06/11/2024 -
Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update
06/11/2024
Pages